Clinical Trials Browser

Phase 3 × Malignant Ascites × 30 days × Clear all

NCT06432296 2026-05-11

Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody

Phase 3 Active not recruiting

Malignant Ascites